Corrigendum: Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells (International Journal of Oncology (2013) 42 (873-880) DOI: 10.3892/ijo.2013.1761);Functional analysis of Zyxin in cell migration and invasive potential of oral squamous cell carcinoma cells

International Journal of Oncology

Volumn 42, Issue 3, 2013, Pages 873-880

  Yamamura, Michiyo ^a   Noguchi, Kazuma ^a   Nakano, Yoshiro ^a   Segawa, Emi ^a   Zushi, Yusuke ^a   Takaoka, Kazuki ^a   Kishimoto, Hiromitsu ^a   Hashimoto Tamaoki, Tomoko ^a   Urade, Masahiro ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Cell migration; Invasion; Morphology; Oral squamous cell carcinoma; siRNA; Zyxin

Indexed keywords

ACTIN; LPP PROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PEPTIDES AND PROTEINS; PROTEIN CDC42; RAC1 PROTEIN; SMALL INTERFERING RNA; TRIP6 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; ZYXIN;

ARTICLE; CARCINOMA CELL; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SHAPE; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE REARRANGEMENT; GENE SILENCING; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC TRANSFECTION; GROWTH CURVE; IMMUNOCYTOCHEMISTRY; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SPINDLE CELL; STRESS FIBER; TUMOR MICROENVIRONMENT; WESTERN BLOTTING;

EID: 84873673028     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2016.3702     Document Type: Erratum

References (40)

1. Pereira MC, Oliveira DT, Landman G and Kowalski LP: Histologic subtypes of oral squamous cell carcinoma: prognostic relevance. J Can Dent Assoc 73: 339-344, 2007.
2. Sudbo J, Bryne M, Mao L, Lotan R, et al: Molecular based treatment of oral cancer. Oral Oncol 39: 749-758, 2003. (Pubitemid 38373459)
3. Leemans CR, Tiwari R, Nauta JJ, van der Waal I and Snow GB: Regional lymph node involvement and significance in the development of distant metastases in head and neck carcinoma. Cancer 71: 452-456, 1993. (Pubitemid 23021234)
4. Leemans CR, Tiwari R, Nauta JJ, van der Waal I and Snow GB: Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer 73: 187-190, 1994. (Pubitemid 24012742)
5. Brattain MG, Willson J, Koterba A, Patil S and Venkateswarlu S: Colorectal cancer. In: Human Cell Culture. Cancer Cell Lines, Part 2. Masters JR, Palsson B (eds). Vol 2. Kluwer Academic Publishers, Norwell, MA, pp293-304, 2002.
6. Kozlowski J and Sensibar JA: Prostate cancer. In: Human Cell Culture. Cancer Cell Lines, Part 2. Masters JR, Palsson B (eds). Vol 2. Kluwer Academic Publishers, Norwell, MA, pp305-332, 2002.
7. Sutherland R, Watts CK, Lee CS and Musgrove EA: Breast cancer. In: Human Cell Culture. Cancer Cell Lines, Part 2. Masters JR, Palsson B (eds). Vol 2. Kluwer Academic Publishers, Norwell, MA, pp79-106, 2002.
8. Yokoyama K, Kamata N, Hayashi E, Hoteiya T, Ueda N, Fujimoto R and Nagayama M: Reverse correlation of E-cadherin and snail expression in oral squamous cell carcinoma cells in vitro. Oral Oncol 37: 65-71, 2001.
9. Frixen UH, Behrens J, Sachs M, et al: E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113: 173-185, 1991. (Pubitemid 21909684)
10. Petit MM, Fradelizi J, Golsteyn RM, et al: LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity. Mol Biol Cell 11: 117-129, 2000. (Pubitemid 30075510)
11. Yi J and Beckerle MC: The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics 49: 314-316, 1998. (Pubitemid 28240700)
12. Grunewald TG, Kammerer U, Schulze E, Schindler D, Hong A, Zimmer M and Butt E: Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells. Exp Cell Res 312: 974-982, 2006.
13. Grunewald TG, Kammerer U, Winkler C, Schindler D, Sickmann A, Honig A and Butt E: Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer 96: 296-305, 2007. (Pubitemid 46160635)
14. Hervy M, Hoffman L and Beckerle MC: From the membrane to the nucleus and back again: bifunctional focal adhesion proteins. Curr Opin Cell Biol 18: 524-532, 2006. (Pubitemid 44332910)
15. Nix DA and Beckerle MC: Nuclear-cytoplasmic shuttling of the focal contact protein, zyxin: a potential mechanism for communication between sites of cell adhesion and the nucleus. J Cell Biol 138: 1139-1147, 1997. (Pubitemid 27386462)
16. Nix DA, Fradelizi J, Bockholt S, Menichi B, Louvard D, Friedich E and Beckerle MC: Targeting of zyxin to sites of actin membrane interaction and to the nucleus. J Biol Chem 276: 34759-34767, 2001.
17. van der Gaag EJ, Leccica MT, Dekker SK, Jalbert NL, Amodeo DM and Byers HR: Role of Zyxin in differential cell spreading and proliferation of melanoma cells and melanocytes. J Invest Dermatol 118: 246-254, 2002. (Pubitemid 34158477)
18. Sperry RB, Bishop SN, Bramwell JJ, et al: Zyxin controls migration in epithelial-mesenchymal transition by mediating actin-membrane linkages at cell-cell junctions. J Cell Physiol 222: 612-624, 2010.
19. Urade M, Sugi M and Miyazaki T: Establishment of three bleomycin-resistant human carcinoma cell lines and their cross resistance to other antitumor agents. Cancer 61: 1501-1507, 1998.
20. Kamata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S and Kuroki T: Growth inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res 46: 1648-1653, 1986. (Pubitemid 16121484)
21. Kawahara E, Okada Y, Nakanishi I, Iwata K, Kojima S, Kumagai S and Yamamoto E: The expression of invasive behavior of differentiated squamous carcinoma cell line evaluated by an in vitro invasion model. Jpn J Cancer Res 84: 409-418, 1993. (Pubitemid 23136000)
22. Kojima S: Experimenral study of invasive activity of oral squamous cell carcinoma. J Juzen Med Soc 101: 266-281, 1992.
23. Hoteiya T, Hayashi E, Satomura K, Kamata N and Nagayama N: Expression of E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice in vivo. J Oral Pathol Med 28: 107-111, 1999. (Pubitemid 29101031)
24. Kawashiri S, Tanaka A, Noguchi N, et al: Invasion and metastasis models of oral squamous carcinoma cell lines. Jpn J Tissue Cult Dent Res 12: 1-13, 2004 (in Japanese).
25. Moriyama M: Development of diffuse invasive (grade4D) human oral squamous cell carcinoma model in severe combined immunodeficiency mice: microangioarchitectual analysis and immunohistochemical study. Oral Oncol 35: 395-400, 1999. (Pubitemid 29276975)
26. Hashitani S, Urade M, Nishimura N, Maeda N, Takaoka K, Noguchi K and Sakurai K: Apoptosis induction enhancement of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head neck carcinoma cell lines. Int J Oncol 23: 665-672, 2003.
27. Hiromoto T, Noguchi K, Yamamura M, et al: Up-regulation of neurophil gelatinase-associated lipocalin in oral squaamous cell carcinoma: relation to cell differentiation. Oncol Rep 26: 1415-1421, 2011.
28. Higashikawa K, Yoneda S, Tobiume K, et al: ΔNp63α-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma. Int J Cancer 124: 2837-2844, 2009.
29. Bendris N, Arsic N, Lemmers B and Bianchard JM: Cyclin A2, Rho GTPases and EMT. Small GTPases: Oct 1, 2012 (Epub ahead of print).
30. Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM and García-García A: Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. Oral Oncol 42: 190-200, 2006. (Pubitemid 43106884)
31. Tanaka N, Odajima T, Ogi K, Ikeda T and Satoh M: Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 89: 557-563, 2003. (Pubitemid 37026443)
32. Krisanaprakornkit S and Iamaroon A: Epithelial-mesenchymal transition in oral squamous cell carcinoma. ISRN Oncol: 681469, 2012.
33. Fradelizi J, Noireaux V, Plastino J, et al: ActA and human zyxin harbor Arp2/3-independent actin-polymerization activity. Nat Cell Biol 3: 699-707, 2001. (Pubitemid 32734247)
34. Beckerle MC: Spatial control of action filament assembly: lessons from Listeria. Cell 95: 741-748, 1998. (Pubitemid 29014454)
35. Kadrmas JL and Beckerle MC: The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5: 920-931, 2004. (Pubitemid 39486543)
36. Reiling JH and Sabatini DM: Stress and mTORture signaling. Oncogene 25: 6373-6383, 2006. (Pubitemid 44582282)
37. Shinto O, Yashiro M, Kawajiri H, Shimizu K, Shimizu T, Miwa A and Hirakawa K: Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer 102: 844-851, 2010.
38. Amsellem V, Kryszke MH, Hervy M, et al: The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells. Exp Cell Res 304: 443-456, 2005. (Pubitemid 40321122)
39. Wendt MK, Allington TM and Schiemann WP: Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol 5: 1145-1168, 2009.
40. Pratt S J, Epple H, Ward M, Feng Y, Braga VM and Longmore GD: The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J Cell Biol 168: 813-824, 2005. (Pubitemid 40328164)